{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:38:54Z","timestamp":1792611534800,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T00:00:00Z","timestamp":1306800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00431-011-1501-y","type":"journal-article","created":{"date-parts":[[2011,5,30]],"date-time":"2011-05-30T07:45:17Z","timestamp":1306741517000},"page":"1337-1342","source":"Crossref","is-referenced-by-count":23,"title":["Life-threatening disseminated tuberculosis as a complication of TNF-\u03b1 blockade in an adolescent"],"prefix":"10.1007","volume":"170","author":[{"given":"Steffen","family":"Hess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Hospach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Nossal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Dannecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Magdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Uhlemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,31]]},"reference":[{"key":"1501_CR1","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1086\/605576","volume":"49","author":"JWC Alffenaar","year":"2009","unstructured":"Alffenaar JWC, van Altena R, B\u00f6kkerink HJ et al (2009) Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis. Clin Infect Dis 49:1080\u20131082","journal-title":"Clin Infect Dis"},{"key":"1501_CR2","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/522993","volume":"45","author":"SM Arend","year":"2007","unstructured":"Arend SM, Leyten AMS, Franken WPJ et al (2007) A patient with de novo tuberculosis during anti-tumor necrosis factor-\u03b1 therapy illustrating diagnostic pitfalls and paradoxical response to treatment. Clin Infect Dis 45:1470\u20131475","journal-title":"Clin Infect Dis"},{"key":"1501_CR3","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3899\/jrheum.091086","volume":"37","author":"K Ben Abdelghani","year":"2010","unstructured":"Ben Abdelghani K, Dran DG, Gottenberg JE et al (2010) Tumor necrosis factor-alpha blockers in SAPHO syndrome. J Rheumatol 37:1699\u20131704","journal-title":"J Rheumatol"},{"key":"1501_CR4","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/592695","volume":"47","author":"TK Blackmore","year":"2008","unstructured":"Blackmore TK, Manning L, Taylor WJ et al (2008) Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin Infect Dis 47:e83\u2013e85","journal-title":"Clin Infect Dis"},{"key":"1501_CR5","first-page":"845","volume":"14","author":"D Buonsenso","year":"2010","unstructured":"Buonsenso D, Serranti D, Valentini P (2010) Management of central nervous system tuberculosis in children: light and shade. Eur Rev Med Pharmacol Sci 14:845\u2013853","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1501_CR6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1086\/506935","volume":"43","author":"P Brassard","year":"2006","unstructured":"Brassard P, Kezouh A, Suissa S (2006) Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis 43:717\u2013722","journal-title":"Clin Infect Dis"},{"key":"1501_CR7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/thx.2003.019224","volume":"59","author":"R Breen","year":"2004","unstructured":"Breen R, Smith C, Bettinson H et al (2004) Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax 59:704\u2013707","journal-title":"Thorax"},{"key":"1501_CR8","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","volume":"52","author":"L Carmona","year":"2005","unstructured":"Carmona L, G\u00f3mez-Reino JJ, Rodr\u00edguez-Valverde V et al (2005) Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 52:1766\u20131772","journal-title":"Arthritis Rheum"},{"key":"1501_CR9","first-page":"S546","volume":"58","author":"DV Cooray","year":"2008","unstructured":"Cooray DV, Moran R, Khanna D et al (2008) Screening, re-screening and treatment of PPD positivity in patients on anti-TNFa therapy (abstract). Arthritis Rheum 58:S546\u2013S547","journal-title":"Arthritis Rheum"},{"key":"1501_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00134-007-0934-2","volume":"34","author":"RP Dellinger","year":"2008","unstructured":"Dellinger RP, Levy MM, Carlet JM et al (2008) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17\u201360","journal-title":"Intensive Care Med"},{"key":"1501_CR11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/rheumatology\/keq122","volume":"49","author":"D Eleftheriou","year":"2010","unstructured":"Eleftheriou D, Gerschman T, Sebire N et al (2010) Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology 49:1505\u20131512","journal-title":"Rheumatology"},{"key":"1501_CR12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/rheumatology\/ken469","volume":"48","author":"AL Endean","year":"2009","unstructured":"Endean AL, Barry SM, Young-Min SA (2009) Possible miliary tuberculosis during adalimumab therapy with negative \u03b3-IFN release assays. Rheumatology 48:319\u2013320","journal-title":"Rheumatology"},{"key":"1501_CR13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/427941","volume":"40","author":"C Garcia-Vidal","year":"2005","unstructured":"Garcia-Vidal C, Rodriguez-Fern\u00e1ndez S, Mart\u00ednez-Lacasa J et al (2005) Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis 40:756\u2013759","journal-title":"Clin Infect Dis"},{"key":"1501_CR14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/clinids\/22.1.188","volume":"22","author":"S George","year":"1996","unstructured":"George S, Papa L, Sheils L et al (1996) Septic shock due to disseminated tuberculosis. Clin Infect Dis 22:188\u2013189","journal-title":"Clin Infect Dis"},{"key":"1501_CR15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjmed.2008.09.018","volume":"122","author":"JT Jacob","year":"2009","unstructured":"Jacob JT, Mehta AK, Leonard MK (2009) Acute forms of tuberculosis in adults. Am J Med 122:12\u201317","journal-title":"Am J Med"},{"key":"1501_CR16","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1183\/09031936.00153408","volume":"33","author":"B Kampmann","year":"2009","unstructured":"Kampmann B, Whittaker E, Williams A et al (2009) Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur Respir J 33:1374\u20131382","journal-title":"Eur Respir J"},{"key":"1501_CR17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00431-008-0730-1","volume":"167","author":"K Magdorf","year":"2008","unstructured":"Magdorf K, Detjen AK (2008) Proposed management of childhood tuberculosis in low-incidence countries. Eur J Pediatr 167:927\u2013938","journal-title":"Eur J Pediatr"},{"key":"1501_CR18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11926-009-0047-8","volume":"11","author":"M Magrey","year":"2009","unstructured":"Magrey M, Khan MA (2009) New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome. Curr Rheumatol Rep 11:329\u2013333","journal-title":"Curr Rheumatol Rep"},{"key":"1501_CR19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)60078-6","volume":"369","author":"AS Malipeddi","year":"2007","unstructured":"Malipeddi AS, Rajendran R, Kallarackal G (2007) Disseminated tuberculosis after anti-TNF\u03b1 treatment. Lancet 369:162","journal-title":"Lancet"},{"key":"1501_CR20","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","volume":"24","author":"G Meintjes","year":"2010","unstructured":"Meintjes G, Wilkinson RJ, Morroni C et al (2010) Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 24:2381\u20132390","journal-title":"AIDS"},{"key":"1501_CR21","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s00134-002-1526-9","volume":"28","author":"P Michel","year":"2002","unstructured":"Michel P, Barbier C, Loubi\u00e8re Y et al (2002) Three cases of septic shock due to tuberculosis without HIV pathology. Intensive Care Med 28:1827\u20131828","journal-title":"Intensive Care Med"},{"key":"1501_CR22","first-page":"240","volume":"76","author":"C Moreno","year":"1989","unstructured":"Moreno C, Taverne J, Mehlert A et al (1989) Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumor necrosis factor from human and murine macrophages. Clin Exp Immunol 76:240\u2013245","journal-title":"Clin Exp Immunol"},{"key":"1501_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1183\/09031936.06.00110205","volume":"28","author":"F Piana","year":"2006","unstructured":"Piana F, Codecasa LR, Cavallerio P et al (2006) Use of a t-cell based test for detection of tuberculosis infection among immunocompromised patients. Eur Respir J 28:31\u201334","journal-title":"Eur Respir J"},{"key":"1501_CR24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/08830738060210040801","volume":"21","author":"JF Schoeman","year":"2006","unstructured":"Schoeman JF, Fieggen G, Seller N et al (2006) Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases. J Child Neurol 21:301\u2013308","journal-title":"J Child Neurol"},{"key":"1501_CR25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/088307380401900402","volume":"19","author":"JF Schoeman","year":"2004","unstructured":"Schoeman JF, Springer P, van Rensburg AJ et al (2004) Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. J Child Neurol 19:250\u2013257","journal-title":"J Child Neurol"},{"key":"1501_CR26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/11532610-000000000-00000","volume":"12","author":"S Shenoi","year":"2010","unstructured":"Shenoi S, Wallace CA (2010) Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review. Paediatr Drugs 12:367\u2013377","journal-title":"Paediatr Drugs"},{"issue":"5","key":"1501_CR27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","volume":"36","author":"I Solovic","year":"2010","unstructured":"Solovic I, Sester M, Gomez-Reino JJ et al (2010) The risk of tuberculosis related to TNF antagonist therapies: a TBNET consensus statement. Eur Respir J 36(5):1185\u20131206","journal-title":"Eur Respir J"},{"key":"1501_CR28","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","volume":"60","author":"F Tubach","year":"2009","unstructured":"Tubach F, Salmon D, Ravaud P et al (2009) Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy. Arthritis Rheum 60:1884\u20131894","journal-title":"Arthritis Rheum"},{"key":"1501_CR29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/QCO.0b013e32832dda55","volume":"22","author":"RS Wallis","year":"2009","unstructured":"Wallis RS (2009) Infectious complications of tumor necrosis factor blockade. Curr Opin Infect Dis 22:403\u2013409","journal-title":"Curr Opin Infect Dis"},{"key":"1501_CR30","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/art.23285","volume":"58","author":"RS Wallis","year":"2008","unstructured":"Wallis RS (2008) Mathematical modeling of the cause of tuberculosis during tumor necrosis factor blockade. Arthritis Rheum 58:947\u2013952","journal-title":"Arthritis Rheum"},{"key":"1501_CR31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(08)70227-5","volume":"8","author":"RS Wallis","year":"2008","unstructured":"Wallis RS (2008) Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis 8:601\u2013611","journal-title":"Lancet Infect Dis"},{"key":"1501_CR32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"RS Wallis","year":"2004","unstructured":"Wallis RS, Broder MS, Wong JY et al (2004) Granulomatous infectious diseases associated with TNF antagonists. Clin Infect Dis 38:1261\u20131265","journal-title":"Clin Infect Dis"},{"key":"1501_CR33","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/424455","volume":"39","author":"RS Wallis","year":"2004","unstructured":"Wallis RS, Broder MS, Wong JY et al (2004) Granulomatous infections due to tumor necrosis factor blockade: correction. Clin Infect Dis 39:1254\u20131256","journal-title":"Clin Infect Dis"},{"key":"1501_CR34","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/598504","volume":"48","author":"RS Wallis","year":"2009","unstructured":"Wallis RS, van Vuuren C, Potgieter S (2009) Adalimumab treatment of life-threatening tuberculosis. Clin Infect Dis 48:1429\u20131432","journal-title":"Clin Infect Dis"},{"key":"1501_CR35","doi-asserted-by":"crossref","unstructured":"Yoo WH (2010) Multiple organ tuberculosis of lung, pleura, and peritoneum in ankylosing spondylitis during adalimumab therapy. Rheumatol Int. doi: 10.1007\/s00296-009-1357-x","DOI":"10.1007\/s00296-009-1357-x"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-011-1501-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-011-1501-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-011-1501-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T10:15:45Z","timestamp":1637748945000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-011-1501-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,31]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1501"],"URL":"https:\/\/doi.org\/10.1007\/s00431-011-1501-y","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,31]]}}}